|
Diabetes Care, Vol 23, Issue 2 241-247, Copyright © 2000 by American Diabetes Association
Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis
EA Whitsel, EJ Boyko and DS Siscovick
Northwest Center for Outcomes Research in Older Adults, Veterans Affairs Puget Sound Health Care System, Health Services Research and Development, Washington 98108, USA. ewhitsel@u.washington.edu
OBJECTIVE: A 1992 consensus statement on autonomic testing portrayed
Bazett's heart rate-corrected QT interval (QT) prolongation as a specific
yet insensitive indicator of diabetic autonomic failure. At that time, only
a few small studies had evaluated the accuracy of QTc. To date, even fewer
studies have evaluated whether its accuracy is influenced by patient
characteristics. RESEARCH DESIGN AND METHODS: We critically appraised 17
studies reporting the sensitivity and specificity of QTc for diabetic
autonomic failure. The studies represented 4,584 patients with diabetes
(mean age 34.9 years, 46% female, 92% with type 1 diabetes, mean duration
of diabetes 14.5 years). We summarized the accuracy of QTc prolongation for
diabetic autonomic failure as an odds ratio (OR) (95% CI) and determined
whether patient and study design characteristics influenced the accuracy of
QTc prolongation by comparing summary receiver operating characteristic
curves. RESULTS: Autonomic failure, defined as > or =1.2+/-0.4 (mean +/-
SD) abnormal of 2.0+/-1.6 administered cardiovascular reflex tests, was
found in 26% (25-28) of patients. The pooled sensitivity and specificity of
QTc > 441+/-8 ms for autonomic failure were 28% (26-29) and 86% (85-87),
respectively. Autonomic failure was 2.26 times (1.90-2.70) more likely to
be present in patients with than in patients without QTc prolongation. At
86% specificity, the sensitivity of QTc prolongation was 46 vs. 12% for men
versus women (P = 0.0077), respectively, and, after adjustment for sex, 66
vs. 17% among patients aged 25 vs. 55 years (P = 0.1902) and 61 vs. 27% at
thresholds of >420 vs. >460 ms, respectively (P = 0.2964).
CONCLUSIONS: QTc prolongation is a specific albeit insensitive indicator of
autonomic failure. Although QTc prolongation is relatively accurate for
men, accuracy may be even greater for young men at low QTc thresholds.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Ziegler and for the KORA Study Group
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population: The MONICA/KORA Augsburg Cohort Study: Response to Salvi et al.
Diabetes Care,
October 1, 2008;
31(10):
e75 - e75.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J M Pappachan, J Sebastian, B C Bino, K Jayaprakash, K Vijayakumar, P Sujathan, and L A Adinegara
Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis
Postgrad. Med. J.,
April 1, 2008;
84(990):
205 - 210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ziegler, C. P. Zentai, S. Perz, W. Rathmann, B. Haastert, A. Doring, C. Meisinger, and for the KORA Study Group
Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population: The MONICA/KORA Augsburg Cohort Study
Diabetes Care,
March 1, 2008;
31(3):
556 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Astrup, L. Tarnow, P. Rossing, B. V. Hansen, J. Hilsted, and H.-H. Parving
Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
Diabetes Care,
February 1, 2006;
29(2):
334 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Whitsel, E. J. Boyko, P. M. Rautaharju, T. E. Raghunathan, D. Lin, R. M. Pearce, S. A. Weinmann, and D. S. Siscovick
Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients
Diabetes Care,
August 1, 2005;
28(8):
2045 - 2047.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Beishuizen, J. W. Jukema, J. T. Tamsma, M. A. van de Ree, J. C. M. van der Vijver, H. Putter, A. C. Maan, A. E. Meinders, and M. V. Huisman
No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
Diabetes Care,
July 1, 2005;
28(7):
1675 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Raimondi, P. De Paoli, E. Mannucci, G. Lonardo, L. Sartiani, G. Banchelli, R. Pirisino, A. Mugelli, and E. Cerbai
Restoration of Cardiomyocyte Functional Properties by Angiotensin II Receptor Blockade in Diabetic Rats
Diabetes,
July 1, 2004;
53(7):
1927 - 1933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Salles, K. V. Bloch, and C. R.L. Cardoso
Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients
Diabetes Care,
June 1, 2004;
27(6):
1299 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kumar, M. Fisher, and P. W Macfarlane
Review: Diabetes and the QT interval: time for debate
The British Journal of Diabetes & Vascular Disease,
May 1, 2004;
4(3):
146 - 150.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
Approaches to Cardiovascular Disease and Its Treatment
Diabetes Care,
December 1, 2003;
26(12):
3342 - 3348.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R.L. Cardoso, G. F. Salles, and W. Deccache
QTc Interval Prolongation Is a Predictor of Future Strokes in Patients With Type 2 Diabetes Mellitus
Stroke,
September 1, 2003;
34(9):
2187 - 2194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Rana, K. J. Mukamal, J. P. Morgan, J. E. Muller, and M. A. Mittleman
Circadian Variation in the Onset of Myocardial Infarction: Effect of Duration of Diabetes
Diabetes,
June 1, 2003;
52(6):
1464 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kempler
Review: Autonomic neuropathy: a marker of cardiovascular risk
The British Journal of Diabetes & Vascular Disease,
March 1, 2003;
3(2):
84 - 90.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Taskiran, T. Fritz-Hansen, V. Rasmussen, H. B.W. Larsson, and J. Hilsted
Decreased Myocardial Perfusion Reserve in Diabetic Autonomic Neuropathy
Diabetes,
November 1, 2002;
51(11):
3306 - 3310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Valensi, N. B. Johnson, P. Maison-Blanche, F. Extramania, G. Motte, and P. Coumel
Influence of Cardiac Autonomic Neuropathy on Heart Rate Dependence of Ventricular Repolarization in Diabetic Patients
Diabetes Care,
May 1, 2002;
25(5):
918 - 923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Poulsen, E. Ebbehøj, H. Arildsen, S. T. Knudsen, K. W. Hansen, H. Mølgaard, and C. E. Mogensen
Increased QTc Dispersion Is Related to Blunted Circadian Blood Pressure Variation in Normoalbuminuric Type 1 Diabetic Patients
Diabetes,
April 1, 2001;
50(4):
837 - 842.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E.A. Whitsel, T.E. Raghunathan, R.M. Pearce, D. Lin, P.M. Rautaharju, R. Lemaitre, and D.S. Siscovick
RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease
Eur. Heart J.,
January 2, 2001;
22(2):
165 - 173.
[Abstract]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|